Press "Enter" to skip to content

New patent expiration for Janssen Pharms drug XARELTO

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Janssen Pharms drug XARELTO

Annual Drug Patent Expirations for XARELTO
Annual Drug Patent Expirations for XARELTO

Xarelto is a drug marketed by Janssen Pharms and is included in one NDA. It is available from three suppliers. There are five patents protecting this drug and two Paragraph IV challenges.

XARELTO drug price trends.

Drug patent litigation for XARELTO.

This drug has one hundred and forty-two patent family members in forty-seven countries.

The generic ingredient in XARELTO is rivaroxaban. Three suppliers are listed for this compound. Additional details are available on the rivaroxaban profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Janssen Pharms drug XARELTO
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions